Antonio Lalueza

ORCID: 0000-0003-2711-3817
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • Antimicrobial Resistance in Staphylococcus
  • Venous Thromboembolism Diagnosis and Management
  • Infective Endocarditis Diagnosis and Management
  • Respiratory Support and Mechanisms
  • COVID-19 and healthcare impacts
  • Sepsis Diagnosis and Treatment
  • Intensive Care Unit Cognitive Disorders
  • Central Venous Catheters and Hemodialysis
  • COVID-19 and Mental Health
  • Bacterial Identification and Susceptibility Testing
  • Pneumonia and Respiratory Infections
  • COVID-19 diagnosis using AI
  • Streptococcal Infections and Treatments
  • Inflammasome and immune disorders
  • Cytomegalovirus and herpesvirus research
  • Tracheal and airway disorders
  • COVID-19 Impact on Reproduction
  • Pediatric Urology and Nephrology Studies
  • Actinomycetales infections and treatment
  • Autoimmune and Inflammatory Disorders Research

Hospital Universitario 12 De Octubre
2015-2025

Universidad Complutense de Madrid
2016-2025

Centro de Investigación Biomédica en Red
2021-2025

Research Institute Hospital 12 de Octubre
2011-2024

Instituto de Salud Carlos III
2018-2024

Johns Hopkins Hospital
2024

All India Institute of Medical Sciences Rishikesh
2023

All India Institute of Medical Sciences Raipur
2023

Hospital Universitario Ramón y Cajal
2016

Institut de Veille Sanitaire
2011

The clinical characteristics, management, and outcome of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 2 (SARS-CoV-2) after solid organ transplant (SOT) remain unknown. We report our preliminary experience with 18 SOT (kidney [44.4%], liver [33.3%], heart [22.2%]) recipients diagnosed COVID-19 March 23, 2020 at a tertiary-care center Madrid. Median age diagnosis was 71.0 ± 12.8 years, the median interval since transplantation 9.3 years. Fever (83.3%)...

10.1111/ajt.15929 article EN cc-by-nc-nd American Journal of Transplantation 2020-04-17

The immune response type organized against viral infection is determinant in the prognosis of some infections. This work has aimed to study Th polarization acute COVID-19 and its possible association with outcome through an observational prospective study. Fifty-eight patients were recruited Medicine Department hospital “12 de Octubre,” 55 remaining after losses follow-up. Four groups established according maximum degree disease progression. T-helper cell percentages phenotypes, analyzed by...

10.3389/fcimb.2021.624483 article EN cc-by Frontiers in Cellular and Infection Microbiology 2021-02-26
Michael G. Ison Alberto Papi Eugene Athan Robert G. Feldman Joanne M. Langley and 95 more Dong‐Gun Lee Isabel Leroux‐Roels Federico Martinón‐Torres Tino F. Schwarz Richard N. van Zyl-Smit Céline Verheust Nancy Dezutter Olivier Gruselle Laurence Fissette Marie‐Pierre David Lusiné Kostanyan Veronica Hulstrøm Aurélie Olivier Marie Van der Wielen Dominique Descamps Mark N. Adams Michael L. Adams Clara Agutu Elaine Jacqueline Akité Ingrid Alt Charles P. Andrews Rafaelle Antonelli-Incalzi Asmik Asatryan Ghazaleh Bahrami Elena Bargagli Qasim Bhorat Paul Bird Przemysław Borowy Céline Boutry Carles Brotons Cuixart David Browder Judith C. Brown Erik Buntinx Donald P. Cameron Laura Cámpora Cyrille Cartier Kenneth Chinsky Melissa Choi Eun Ju Choo Delphine Collete Maria Corral Carrillo Susanna Cuadripani Matthew Davis Magali de Heusch Ferdinandus de Looze Marc De Meulemeester Ferdinando De Negri Nathalie De Schrevel David DeAtkine Viktoriya Dedkova Peter Dzongowski Tamara Eckermann Brandon Essink Karen Faulkner Murdo Ferguson Gregory N. Fuller Isabel Maria Galan Melendez Ivan Gentile Wayne Ghesquière Doria Grimard Scott A. Halperin Amardeep Heer Laura Helman Andre Hotermans Tomáš Jelı́nek Jackie Kamerbeek Hyo Youl Kim Murray Kimmel Mark Koch Satu Kokko Susanna Koski Shady Kotb Antonio Lalueza Jin Soo Lee Muriel Lins Johannes Lombaard Akbar Mahomed Mario Malerba Céline Maréchal Sandie Marion Jean‐Benoît Martinot Cristina Masuet‐Aumatell Damien McNally Carlos Eduardo Medina Pech J M Gonzalez Galvan Lise Mercati Narcisa Mesaros Dieter Mesotten Essack Mitha Kathryn Mngadi Beate Moeckesch Barnaby Montgomery Linda Murray Rhiannon Nally Silvia Narejos Pérez

Abstract Background The adjuvanted RSV prefusion F protein–based vaccine (RSVPreF3 OA) was efficacious against RSV-related lower respiratory tract disease (RSV-LRTD) in ≥60-years-olds over 1 season. We evaluated efficacy and safety of RSVPreF3 OA dose 2 doses given year apart RSV-LRTD seasons post–dose 1. Methods In this phase 3, blinded trial, ≥60-year-olds were randomized (1:1) to receive or placebo pre–season recipients re-randomized a second (RSV_revaccination group) (RSV_1dose 2;...

10.1093/cid/ciae010 article EN cc-by Clinical Infectious Diseases 2024-01-22
Robert G. Feldman Raffaele Antonelli Incalzi Katie Steenackers Dong‐Gun Lee Alberto Papi and 95 more Michael G. Ison Laurence Fissette Marie‐Pierre David Céline Maréchal Marie Van der Wielen Lusiné Kostanyan Veronica Hulstrøm Mark Adams Michael L. Adams Elaine Jacqueline Akité Ingrid Alt Charles P. Andrews Asmik Asatryan Eugene Athan Ghazaleh Bahrami Elena Bargagli Qasim Bhorat Paul Bird Przemysław Borowy Céline Boutry Carles Brotons Cuixart David Browder Judith C. Brown Erik Buntinx Donald P. Cameron Laura Cámpora Kenneth Chinsky Melissa Choi Eun Ju Choo Delphine Collete Maria Corral Carrillo Matthew Davis Magali de Heusch Ferdinandus de Looze Marc De Meulemeester Ferdinando De Negri Nathalie De Schrevel David DeAtkine Viktoriya Dedkova Dominique Descamps Nancy Dezutter Peter Dzongowski Tamara Eckermann Brandon Essink Karen Faulkner Murdo Ferguson Gregory N. Fuller Isabel Maria Galan Melendez Ivan Gentile Wayne Ghesquière Doria Grimard Olivier Gruselle Scott A. Halperin Amardeep Heer Laura Helman Andre Hotermans Tomáš Jelı́nek Jackie M Kamerbeek Hyo Youl Kim Murray Kimmel Mark Koch Satu Kokko Susanna Koski Shady Kotb Antonio Lalueza Joanne M. Langley Jin Soo Lee Isabel Leroux‐Roels Muriel Lins Johannes Lombaard Akbar Mahomed Mario Malerba Céline Maréchal Federico Martinón‐Torres Jean‐Benoît Martinot Cristina Masuet‐Aumatell Damien McNally Carlos Eduardo Medina Pech J M Gonzalez Galvan Narcisa Mesaros Dieter Mesotten Essack Mitha Kathryn Mngadi Beate Moeckesch Barnaby Montgomery Linda Murray Rhiannon Nally Silvia Narejos Pérez Joseph L. Newberg Paul Nugent Dolores Ochoa Mazarro Harunori Oda Aurélie Olivier Maurizio Orso Jacinto Ortiz Molina

Abstract Background Older adults with chronic cardiorespiratory or endocrine/metabolic conditions are at increased risk of respiratory syncytial virus (RSV)-related acute illness (RSV-ARI) and severe disease. In an ongoing, randomized, placebo-controlled, multicountry, phase 3 trial in ≥60-year-old participants, AS01E-adjuvanted RSV prefusion F protein-based vaccine (RSVPreF3 OA) was efficacious against RSV-related lower tract disease (RSV-LRTD), RSV-LRTD, RSV-ARI. We evaluated efficacy...

10.1093/cid/ciad471 article EN cc-by Clinical Infectious Diseases 2023-09-12

Background. The influence of acute graft pyelonephritis (AGPN) on outcome in renal transplant recipients still remains controversial. Methods. We retrospectively analysed 189 patients (113 males; mean age: 49.7 ± 13.1 years) undergoing transplantation at the University Hospital 12 de Octubre (Madrid, Spain) from January 2002 to December 2004, with a minimum follow-up 36 months. Factors associated AGPN were assessed by logistic regression analysis. Long-term function was compared according...

10.1093/ndt/gfq531 article EN Nephrology Dialysis Transplantation 2010-08-30

BackgroundInformation regarding the incidence and characteristics of COVID-19 pneumonia amongst pregnant women is scarce.MethodsSingle-centre experience with 32 diagnosed between March 5 to April 5, 2020 at Madrid, Spain.FindingsCOVID-19 was in 61·5% (32/52) women. Only 18·7% (6/32) had some underlying condition (mostly asthma). Supplemental oxygen therapy required 18 patients (56·3%), high-flow requirements six (18·7%). Eight (25·0%) fulfilled criteria for acute distress respiratory...

10.1016/j.eclinm.2020.100407 article EN cc-by-nc-nd EClinicalMedicine 2020-06-01

The aim of our study was to elucidate if SARS-CoV-2 viral load on admission, measured by real-time reverse transcriptase–polymerase chain reaction (rRT-PCR) cycle threshold (Ct) value nasopharyngeal samples, a marker disease severity. All hospitalized adult patients with diagnosis infection rRT-PCR performed nasopharingeal sample from March 1 18 in institution were included. population divided according the Ct obtained upon admission high (Ct < 25), intermediate (Ct: 25–30) and low > 30)....

10.1007/s10096-020-04150-w article EN other-oa European Journal of Clinical Microbiology & Infectious Diseases 2021-01-07

The timing of the development specific adaptive immunity after natural SARS-CoV-2 infection, and its relevance in clinical outcome, has not been characterized depth. Description long-term maintenance both cellular humoral responses elicited by real-world anti-SARS-CoV-2 vaccination is still scarce. Here we aimed to understand optimal protective infection vaccination. We performed an early, longitudinal study S1-, M- N-specific IFN-γ IL-2 T cell anti-S total neutralizing antibodies 88 mild,...

10.1371/journal.ppat.1010211 article EN cc-by PLoS Pathogens 2021-12-28

An early analysis of circulating monocytes may be critical for predicting COVID-19 course and its sequelae. In 131 untreated, acute patients at emergency room arrival, showed decreased surface molecule expression, including low HLA-DR, in association with an inflammatory cytokine status limited anti-SARS-CoV-2-specific T cell response. Most these alterations had normalized post-COVID-19 6 months after discharge. Acute transcriptome upregulation anti-inflammatory tissue repair genes such as...

10.3390/biomedicines9091253 article EN cc-by Biomedicines 2021-09-17
Behnood Bikdeli César Caraballo Javier Trujillo‐Santos J.‐P. Galanaud Pierpaolo Di Micco and 95 more V. Rosa Gemma Vidal Cusidó Sebastian Schellong Meritxell Mellado María del Valle Morales Olga Gavín‐Sebastián Lucia Mazzolai Harlan M. Krumholz Manuel Monréal Paolo Prandoni Benjamin Brenner Dominique Farge Raquel Barba Laurent Bertoletti Inna Tzoran Abílio Reis Marijan Bosevski Henri Bounameaux Radován Malý Peter Verhamme Joseph A. Caprini María Dolores Adarraga Paloma Agudo de Blas Jesús Aibar Cristina Amado Juan I. Arcelus Aitor Ballaz Cristina Barbagelata Manuel Barrón B. Barrón‐Andrés Ángeles Blanco‐Molina Fahd Beddar Chaib Ernesto Botella Beatriz Buño-Ramilo Joaquín Castro Leyre Chasco Juan Criado Cristina de Ancos Javier de Miguel-Dı́ez J. del Toro Pablo Demelo‐Rodríguez Ana María Díaz-Brasero Carmen Díaz‐Pedroche José Antonio Díaz‐Peromingo Raquel Díaz‐Simón Irene Milagros Domínguez Álvaro Dubois-Silva José Carlos Escribano F. Espósito Ana Isabel Farfán‐Sedano Carmen Fernández‐Capitán José Luis Fernández‐Reyes Ángeles Fidalgo Carme Font Iria Francisco Cristina Gabara Francisco Galeano‐Valle Maria A. García F. García‐Bragado Marta García de Herreros Rocío García de la Garza Covadonga García-Díaz A. Gil-Díaz M. Giménez-Suau Covadonga Gómez‐Cuervo Enric Grau Leticia Guirado Javier Cuesta Luis Blasco Luis Jara‐Palomares M.J. Jaras David Jiménez Rafael Jiménez Carmen Jiménez-Alfaro I. Jou M.D. Joya S. Lainez-Justo Antonio Lalueza Ana Latorre-Díez José Luís Lobo Luciano López‐Jiménez Patricia López-Miguel Juan J. López-Núñez Raquel López-Reyes J.B. López‐Sáez Alicia Lorenzo Olga Madridano Ana Maestre Pablo Javier Marchena M. Martín del Pozo F. Martín‐Martos Diego Martínez‐Urbistondo C Mella María Isabel Mercado Arturo Muñoz Blanco

Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, in infrapopliteal veins without proximal extension or pulmonary embolism (PE).To determine characteristics, 1-year IDDVT to compare unadjusted multivariable adjusted analyses who had DVT.This was a multicenter, international cohort study participating sites Registro Informatizado Enfermedad Tromboembólica (RIETE) registry...

10.1001/jamacardio.2022.1988 article EN JAMA Cardiology 2022-07-13

The Th1/Th2 balance plays a crucial role in the progression of different pathologies and is determining factor evolution infectious diseases. This work has aimed to evaluate early, or on diagnosis, T-cell compartment response, T-helper subsets anti-SARS-CoV-2 antibody specificity COVID-19 patients classify them according based infection severity. A unicenter, randomized group 146 was divided into four groups accordance with most critical events during course disease. immunophenotype were...

10.3390/biomedicines10020296 article EN cc-by Biomedicines 2022-01-27

Abstract We conducted a retrospective study of 99 patients with methicillin-suseptible Staphylococcus aureus catheter-related bacteremia in which vancomycin MIC was determined by Etest. High (>1.5 μg/mL) the only independent risk factor for development complicated caused methicillin-susceptible S. (odds ratio 22.9, 95% confidence interval 6.7–78.1).

10.3201/eid/1706.101037 article EN cc-by Emerging infectious diseases 2011-06-01

We analyzed the frequency of cognitive impairment (CI) in deceased COVID-19 patients at a tertiary hospital Spain. Among 477 adult cases who died after admission from March 1 to 31, 2020, 281 had confirmed COVID-19. CI (21.1% dementia and 8.9% mild impairment) was common comorbidity. Subjects with were older, tended live nursing homes, shorter time symptom onset death, rarely admitted ICU, receiving palliative care more often. is frequent comorbidity subjects associated differences care.

10.3233/jad-200937 article EN Journal of Alzheimer s Disease 2020-10-13

Despite the growing number of patients with persistent symptoms after acute SARS-CoV-2 infection, pathophysiology underlying long-COVID is not yet well characterized, and there no established therapy. We performed a deep immune profiling in nine (PSP), before 4-day prednisone course, five post-COVID-19 without (NSP). PSP showed perturbed distribution circulating mononuclear cell populations. Symptoms were accompanied by pro-inflammatory phenotype characterized increased conventional...

10.3390/biomedicines9111540 article EN cc-by Biomedicines 2021-10-26

A. Garcia‐Reyne, F. López‐Medrano, J.M. Morales, C. García Esteban, I. Martín, Eraña, Y. Meije, Lalueza, Alastruey‐Izquierdo, J.L. Rodríguez‐Tudela, Aguado. Cutaneous infection by Phomopsis longicolla in a renal transplant recipient from Guinea: first report of human this fungus. Transpl Infect Dis 2011: 13: 204–207. All rights reserved Abstract: We the case 72‐year‐old female with nodular lesion distal phalange third left finger produced dematiaceous fungus that was identified as . She...

10.1111/j.1399-3062.2010.00570.x article EN Transplant Infectious Disease 2010-09-07

Objective Patients with coronavirus disease 2019 (COVID‐19) present coagulation abnormalities and thromboembolic events that resemble antiphospholipid syndrome (APS). This work has aimed to study the prevalence of APS‐related antigens, antibodies, immune complexes in patients COVID‐19 their association clinical events. Methods A prospective was conducted on 474 adults severe acute respiratory 2 infection hospitalized two Spanish university hospitals. were evaluated for classic extra‐criteria...

10.1002/acr2.11245 article EN cc-by-nc-nd ACR Open Rheumatology 2021-03-19

Age and comorbidity are the main determinants of COVID-19 outcome. Shorter leukocyte telomere length (TL), a hallmark biological aging, has been associated with worse outcomes. We sought to determine TL in patients severe requiring hospitalization analyze whether clinical outcomes post-COVID-19 manifestations shorter TL.We analyzed 251 PCR-confirmed COVID-19, hospitalized first months pandemics. determined PBL at admission by quantitative-PCR (qPCR) analysis patients. A healthy cohort from...

10.1186/s12979-022-00294-9 article EN cc-by Immunity & Ageing 2022-08-22

The aim of this study was to analyze whether the coronavirus disease 2019 (COVID-19) vaccine reduces mortality in patients with moderate or severe COVID-19 requiring oxygen therapy. A retrospective cohort study, data from 148 hospitals both Spain (111 hospitals) and Argentina (37 hospitals), conducted. We evaluated hospitalized for older than 18 years requirements. Vaccine protection against death assessed through a multivariable logistic regression propensity score matching. also performed...

10.1002/jmv.28786 article EN cc-by-nc-nd Journal of Medical Virology 2023-05-01
Coming Soon ...